Karyomegalic-like nephropathy, Ewing's sarcoma and ifosfamide therapy

Pediatric Nephrology

Volumn 26, Issue 7, 2011, Pages 1163-1166

  McCulloch, Tom ^a   Prayle, Andrew ^b   Lunn, Andy ^b   Watson, Alan R ^b  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Children; Ewing's sarcoma; Ifosfamide; Karyomegalic nephropathy; Nephrotoxicity

Indexed keywords

BICARBONATE; BISPHOSPHONIC ACID DERIVATIVE; CARBOPLATIN; CORTICOSTEROID; CREATININE; CYCLIZINE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INDOMETACIN; PHOSPHATE; POTASSIUM; VINCRISTINE; VITAMIN D;

ABDOMINAL PAIN; ACUTE ABDOMEN; ADOLESCENT; ARTICLE; CALCANEUS FRACTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHRONIC KIDNEY DISEASE; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; ENTERITIS; EWING SARCOMA; FEMALE; FOLLOW UP; FOOT FRACTURE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KARYOMEGALIC INTERSTITIAL NEPHROPATHY; KIDNEY BIOPSY; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DISORDER; LIMB PAIN; LUNG METASTASIS; MALE; METABOLIC BONE DISEASE; METATARSUS FRACTURE; NEUROPATHIC PAIN; ORTHOPEDIC SURGERY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TUMOR RECURRENCE; URINE INCONTINENCE; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOPSY; CELL NUCLEUS SHAPE; CHRONIC DISEASE; DISEASE PROGRESSION; EPITHELIAL CELLS; FATAL OUTCOME; FEMALE; HUMANS; IFOSFAMIDE; KIDNEY TUBULES; MALE; NEPHRITIS, INTERSTITIAL; RENAL DIALYSIS; SARCOMA, EWING'S; TREATMENT OUTCOME;

EID: 80052516124     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1815-z     Document Type: Article

References (15)

1. Burry AF (1974) Extreme dysplasia in renal epithelium of a young woman dying from hepatocarcinoma. J Pathol 113:147-150.
2. Mihatsch MJ, Gudat F, Zollinger HU, Heierli C, Tholen H, Reutter FW (1979) Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity? Clin Nephrol 12:54-62. (Pubitemid 10222945)
3. Bhandari S, Kalowski S, Collett P, Cooke BE, Kerr P, Newland R, Dowling J, Horvath J (2002) Karyomegalic nephropathy: an uncommon cause of progressive renal failure. Nephrol Dial Transplant 17:1914-1920. (Pubitemid 35277087)
4. Colvin RB, Nikeleit V (2007) Polyomavirus nephropathy. In: Jenette JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's pathology of the kidney. Lippincott Williams & Wilkins, Philadelphia, pp 1441-1447.
5. Spoendlin M, Moch H, Brunner F, Brunner W, Burger HR, Kiss D, Wegmann W, Dalquen P, Oberholzer M, Thiel G, Mihatsch MJ (1995) Karyomegalic interstitial nephritis: further support for a distinct entity and evidence for a genetic defect. Am J Kidney Dis 25:242-252.
6. Monga G, Banfi G, Salvadore M, Amatruda O, Bozzola C, Mazzucco G (2006) Karyomegalic interstitial nephritis: report of 3 new cases and review of the literature. Clin Nephrol 65:349-355. (Pubitemid 43676420)
7. Hassen W, Abid-Essafi S, Achour A, Guezzah N, Zakhama A, Ellouz F, Creppy EE, Bacha H (2004) Karyomegaly of tubular kidney cells in human chronic interstitial nephropathy in Tunisia: respective role of Ochratoxin A and possible genetic predisposition. Hum Exp Toxicol 23:339-346. (Pubitemid 39117529)
8. Stohr W, Paulides M, Bielack S, Jurgens H, Treuner J, Rossi R, Langer T, Beck JD (2007) Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 48:447-452. (Pubitemid 46340112)
9. Skinner R, Cotterill SJ, Stevens MC (2000) Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group. Br J Cancer 82:1636-1645. (Pubitemid 30229572)
10. Loebstein R, Atanackovic G, Bishai R, Wolpin J, Khattak S, Hashemi G, Gobrial M, Baruchel S, Ito S, Koren G (1999) Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 39:454-461. (Pubitemid 29356465)
11. Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson AD (2010) Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose. Pediatr Blood Cancer 54:983-989.
12. Slavin RE, Millan JC, Mullins GM (1975) Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol 6:693-709.
13. Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE (1995) Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients. Cancer 76:497-500.
14. Willemse PH, de Jong PE, Elema JD, Mulder NH (1989) Severe renal failure following high-dose ifosfamide and mesna. Cancer Chemother Pharmacol 23:329-330. (Pubitemid 19087695)
15. Friedlaender MM, Haviv YS, Rosenmann E, Peylan-Ramu N (1998) End-stage renal interstitial fibrosis in an adult ten years after ifosfamide therapy. Am J Nephrol 18:131-133. (Pubitemid 28161819)